This Viewpoint discusses the potential risks of the US Food and Drug Administration’s 2016 approval of the Dexcom G5 Mobile continuous glucose monitor for making diabetes treatment decisions without confirmation of the device’s readings with fingerstick or laboratory testing.
This population-based cohort study compares rates of severe hypoglycemia and diabetic ketoacidosis among children, adolescents, and young adults with type 1 diabetes managed with insulin pump therapy vs insulin injection therapy.
This Medical News article discusses research exploring the clinical potential of a chemically modified dietary starch to protect against type 1 diabetes and other diseases.
This crossover nonineriority trial compared the effects of insulin degludec with insulin glargine U100 in reducing on rates of symptomatic hypoglycemic episodes among adult patients with type 1 diabetes.
This cohort study uses diabetes registry data to compare rates of complications related to type 1 vs type 2 diabetes among teenagers and young adults diagnosed with diabetes during childhood and adolescence.
This randomized clinical trial evaluated the effectiveness of continuous glucose monitoring vs usual care on hemoglobin A1c levels in adults with type 1 diabetes who use multiple daily insulin injections.
This randomized clinical trial compares the effects of continuous glucose monitoring vs conventional treatment for glycemic control in adult patients with type 1 diabetes treated with multiple daily insulin injections.
This study describes the safety of a hybrid closed-loop insulin delivery system among patients with type 1 diabetes.
This meta-analysis summarizes evidence about associations between timing of allergenic food introduction during infancy and risk of allergic or autoimmune disease.
This population epidemiology study uses regional claims data from Germany to investigate associations between infections in the first 2 years of life and development of type 1 diabetes.
This randomized trial reports that the addition of metformin to insulin does not improve glycemic control in overweight adolescents with type 1 diabetes and increases incidence of gastrointestinal adverse events.
This narrative review summarizes current thinking about the diagnosis and treatment of distal symmetric polyneuropathy.
You currently have no searches saved.